Serving as lead defense counsel, reached a confidential and amicable settlement on behalf of a multinational materials technology company in a multi-jurisdictional trade secret and breach of contract litigation brought by a competitor. Dispute related to an M&A transaction under which Defendant had purchased certain business assets from Plaintiff. At stake were the Defendant’s rights to develop and introduce emissions control catalyst products into a growing, global market. Served as lead counsel in the U.S. litigation as well as in the arbitration that was pending in Sweden at the time of resolution.

Represented Medinol in the assertion of patents relating to coronary stents against Cordis and Johnson & Johnson in the Southern District of New York. (Prior to joining Robins Kaplan LLP)

Represented Umicore in multiple Inter Parties Review proceedings instituted by the United States Patent and Trademark Office challenging the validity of patents owned by competitor BASF Corporation, claiming catalysts and diesel exhaust gas treatment systems. (Prior to joining Robins Kaplan LLP)

Represented Covidien in defense of its single incision laparoscopic access device against patent infringement claims brought by Applied Medical in the Central District of California. (Prior to joining Robins Kaplan LLP)

Represented Organon and Biotechnology General in the assertion of patent claims protecting Organon's branded MIRCETTE® product against Barr and Duramed's generic oral contraceptive. (Prior to joining Robins Kaplan LLP)

Represented Barnes & Noble in defense of its NOOK® eReader against claims brought by Microsoft Corporation in the ITC for infringement of patents relating to computer software. (Prior to joining Robins Kaplan LLP)

Represented the Heirs of Richard Ritchie, the formulator of Pepsi Cola, against Pepsico, Inc. concerning the heirs' ownership of certain documents and intellectual property relating to Pepsi Cola. (Prior to joining Robins Kaplan LLP)